ZA922815B - Pyrimidine derivatives for enhancing antitumor activity - Google Patents

Pyrimidine derivatives for enhancing antitumor activity

Info

Publication number
ZA922815B
ZA922815B ZA922815A ZA922815A ZA922815B ZA 922815 B ZA922815 B ZA 922815B ZA 922815 A ZA922815 A ZA 922815A ZA 922815 A ZA922815 A ZA 922815A ZA 922815 B ZA922815 B ZA 922815B
Authority
ZA
South Africa
Prior art keywords
antitumor activity
pyrimidine derivatives
enhancing antitumor
enhancing
derivatives
Prior art date
Application number
ZA922815A
Other languages
English (en)
Inventor
Jotham Wadsworth Coe
Anton Franz J Fliri
Takushi Kaneko
Eric Robert Larson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA922815B publication Critical patent/ZA922815B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA922815A 1991-04-17 1992-04-16 Pyrimidine derivatives for enhancing antitumor activity ZA922815B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68689991A 1991-04-17 1991-04-17

Publications (1)

Publication Number Publication Date
ZA922815B true ZA922815B (en) 1993-10-18

Family

ID=24758194

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA922815A ZA922815B (en) 1991-04-17 1992-04-16 Pyrimidine derivatives for enhancing antitumor activity

Country Status (22)

Country Link
EP (1) EP0580753B1 (es)
JP (1) JPH0819121B2 (es)
CN (1) CN1065863A (es)
AT (1) ATE119157T1 (es)
AU (1) AU653601B2 (es)
BR (1) BR9205906A (es)
CA (1) CA2108561A1 (es)
CZ (1) CZ390992A3 (es)
DE (2) DE9290039U1 (es)
DK (1) DK0580753T3 (es)
ES (1) ES2068714T3 (es)
FI (1) FI934565A (es)
GR (1) GR3015921T3 (es)
HU (1) HUT65177A (es)
IE (1) IE64915B1 (es)
MX (1) MX9201763A (es)
NO (1) NO933722L (es)
NZ (1) NZ242390A (es)
PT (1) PT100386A (es)
WO (1) WO1992018498A1 (es)
YU (1) YU39992A (es)
ZA (1) ZA922815B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN188411B (es) * 1997-03-27 2002-09-21 Yuhan Corp
US6440965B1 (en) 1997-10-15 2002-08-27 Krenitsky Pharmaceuticals, Inc. Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system
KR100272471B1 (ko) 1998-11-17 2000-11-15 김선진 신규의 피리미딘 유도체 및 그의 제조방법
JP2003521468A (ja) 1999-03-17 2003-07-15 シグナル ファーマシューティカルズ, インコーポレイテッド エストロゲンレセプタを変調させるための化合物及び方法
US6593322B1 (en) 1999-03-17 2003-07-15 Signal Pharmaceuticals, Inc. Compounds and methods for modulation of estrogen receptors
US6583148B1 (en) 1999-04-08 2003-06-24 Krenitsky Pharmaceuticals, Inc. Neurotrophic substituted pyrimidines
US6630469B2 (en) * 2000-05-09 2003-10-07 Bristol-Myers Squibb Company 5-HT7 receptor antagonists
ES2346513T3 (es) 2000-07-24 2010-10-18 Krenitsky Pharmaceuticals, Inc. 5-alquinil pirimidinas sustituidas que tienen actividad neurotrofica.
JP2005232081A (ja) * 2004-02-19 2005-09-02 Bayer Cropscience Ag ベンジルピリミジン誘導体の農園芸用殺菌剤としての利用
JP2010111702A (ja) 2009-02-16 2010-05-20 Tetsuya Nishio 複素環化合物、その製造法および用途
CN103333119A (zh) * 2013-05-28 2013-10-02 中国药科大学 1,2-二氢-6-甲基-4-取代氨基-5-嘧啶羧酸类化合物及其制备方法和用途
CN115232076A (zh) * 2022-07-25 2022-10-25 南通大学 苯氨基取代的嘧啶氨基酸衍生物及其制备方法与应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU206337B (en) * 1988-12-29 1992-10-28 Mitsui Petrochemical Ind Process for producing pyrimidine derivatives and pharmaceutical compositions
JP2744663B2 (ja) * 1988-12-29 1998-04-28 三井化学株式会社 ピリミジン類及びその薬学的に許容される塩類

Also Published As

Publication number Publication date
ATE119157T1 (de) 1995-03-15
AU653601B2 (en) 1994-10-06
DE9290039U1 (de) 1993-12-09
AU1776192A (en) 1992-11-17
NO933722D0 (no) 1993-10-15
EP0580753B1 (en) 1995-03-01
ES2068714T3 (es) 1995-04-16
IE921214A1 (en) 1992-10-21
EP0580753A1 (en) 1994-02-02
NZ242390A (en) 1994-09-27
FI934565A0 (fi) 1993-10-15
BR9205906A (pt) 1994-07-05
DE69201559D1 (de) 1995-04-06
JPH06501023A (ja) 1994-01-27
CN1065863A (zh) 1992-11-04
MX9201763A (es) 1992-10-01
FI934565A (fi) 1993-10-15
IE64915B1 (en) 1995-09-20
YU39992A (sh) 1995-01-31
GR3015921T3 (en) 1995-07-31
NO933722L (no) 1993-10-15
DK0580753T3 (da) 1995-07-03
DE69201559T2 (de) 1995-07-13
HU9302929D0 (en) 1993-12-28
HUT65177A (en) 1994-05-02
CZ390992A3 (en) 1994-03-16
PT100386A (pt) 1993-06-30
JPH0819121B2 (ja) 1996-02-28
WO1992018498A1 (en) 1992-10-29
CA2108561A1 (en) 1992-10-18

Similar Documents

Publication Publication Date Title
IL100942A0 (en) 2,4-diaminoquinazoline derivatives for enhancing antitumor activity
IL99906A0 (en) Quinazoline derivatives for enhancing antitumor activity
DE69716135D1 (en) In 6-position durch thio substituierte paclitaxele
GR3015921T3 (en) Pyrimidine derivatives for enhancing antitumor activity.
IL103655A0 (en) Triazine derivatives for enhancing antitumor activity
AP9300595A0 (en) Intecticidal 5-substituted-2, 4-diaminopyrimidine derivatives
ES2001108A6 (es) Un procedimiento para la preparacion de un derivado de gem-dihalo-1,8-diamino -4 -aza-octano.
IE863201L (en) Diamino pyrimidine derivatives.
PH29996A (en) Pyrimidine or triazine derivatives